Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zamora

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 25, 2020
Heart failure, zip code, and telemetry: a trinomial in need of understandingAlberto Zamora, Agnés Rivera
Revista Espanola De Cardiologia|July 13, 2002
[Prognosis of diabetic patients with ischemic cardiopathy]Alberto Zamora, Jaume Marrugat
Revista Espanola De Cardiologia (English Ed.)|April 2, 2019
Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors. ResponseAlberto Zamora, Luis Masana, Nuria Plana, et al.
Cardiovascular Diseases|December 1, 1981
A normal coronary arteriogram in a very young man with Prinzmetal's variant angina: Case report with review of the literatureAlfredo Balvanera, Julio Frade, Alberto Zamora, et al.
Revista Espanola De Cardiologia (English Ed.)|December 9, 2014
Theoretical impact on coronary disease of using a computerized clinical decision support system in the prescription of lipid-lowering treatmentAlberto Zamora, Carme Carrion, Gabriel Vázquez-Oliva, et al.
Advances in Therapy|December 16, 2022
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in SpainJuan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, et al.
Entropy (Basel, Switzerland)|February 26, 2025
Analysis of Aftershocks from California and Synthetic Series by Using Visibility Graph AlgorithmAlejandro Muñoz-Diosdado, Ana María Aguilar-Molina, Eric Eduardo Solis-Montufar, et al.
Revista Espanola De Cardiologia (English Ed.)|August 5, 2011
Extreme QT interval prolongation and helicoid ventricular tachycardia (torsade de pointes) in non-ST-elevation acute coronary syndromeMontse Vilaseca-Corbera, Gabriel Vázquez-Oliva, Cristina Campoamor-Cela, et al.
Scientific Reports|September 30, 2017
The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass indexIrene R Dégano, Jaume Marrugat, Maria Grau, et al.
Atherosclerosis|June 24, 2003
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patientsJoan Vendrell, José Manuel Fernandez-Real, Cristina Gutierrez, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|July 25, 2020
Heart failure, zip code, and telemetry: a trinomial in need of understandingAlberto Zamora, Agnés Rivera
Revista Espanola De Cardiologia|July 13, 2002
[Prognosis of diabetic patients with ischemic cardiopathy]Alberto Zamora, Jaume Marrugat
Revista Espanola De Cardiologia (English Ed.)|April 2, 2019
Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors. ResponseAlberto Zamora, Luis Masana, Nuria Plana, et al.
Cardiovascular Diseases|December 1, 1981
A normal coronary arteriogram in a very young man with Prinzmetal's variant angina: Case report with review of the literatureAlfredo Balvanera, Julio Frade, Alberto Zamora, et al.
Revista Espanola De Cardiologia (English Ed.)|December 9, 2014
Theoretical impact on coronary disease of using a computerized clinical decision support system in the prescription of lipid-lowering treatmentAlberto Zamora, Carme Carrion, Gabriel Vázquez-Oliva, et al.
Advances in Therapy|December 16, 2022
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in SpainJuan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, et al.
Entropy (Basel, Switzerland)|February 26, 2025
Analysis of Aftershocks from California and Synthetic Series by Using Visibility Graph AlgorithmAlejandro Muñoz-Diosdado, Ana María Aguilar-Molina, Eric Eduardo Solis-Montufar, et al.
Revista Espanola De Cardiologia (English Ed.)|August 5, 2011
Extreme QT interval prolongation and helicoid ventricular tachycardia (torsade de pointes) in non-ST-elevation acute coronary syndromeMontse Vilaseca-Corbera, Gabriel Vázquez-Oliva, Cristina Campoamor-Cela, et al.
Scientific Reports|September 30, 2017
The association between education and cardiovascular disease incidence is mediated by hypertension, diabetes, and body mass indexIrene R Dégano, Jaume Marrugat, Maria Grau, et al.
Atherosclerosis|June 24, 2003
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patientsJoan Vendrell, José Manuel Fernandez-Real, Cristina Gutierrez, et al.
Pageof 6